Literature DB >> 22287372

Utility of novel 3-dimensional stereoscopic vision system for endoscopic sinonasal and skull-base surgery.

R Peter Manes1, Sam Barnett, Pete S Batra.   

Abstract

BACKGROUND: The objective of this pilot study was to evaluate the utility of novel 3-dimensional (3D) endoscopy during endoscopic sinonasal and skull base surgery.
METHODS: Eight surgeries were performed in 7 patients between August 2009 and March 2010 at a tertiary care academic medical center. A high-definition 2-dimensional (2D) endoscopy system was employed in all cases. The Visionsense stereoscopic system (Orangeburg, NY) was incorporated during key portions of the procedures. Two independent surgeons assessed utility of the technology for the following 2 variables: (1) ability to facilitate orientation and depth perception; and (2) impact on completeness of surgery and potential complications.
RESULTS: The mean age was 50.4 years and the male:female ratio was 6:1. Indications included anterior skull base (ASB) tumor resection (5), directed skull base biopsies (2), and ethmoid dissection adjacent to dehiscent skull base/optic nerve in allergic fungal rhinosinusitis (1). Endoscopic orientation and depth perception was aided using the 3D endoscope in all cases. Additional interventions were performed in 3 cases (37.5%), including tumor resection (1) and removal of remnant ethmoid partitions (2). Limitations posed included inability to visualize a type III frontal cell (1) and loss of orientation during ASB reconstruction due to overmagnification (1). No complications were observed in this patient series.
CONCLUSION: This preliminary study demonstrated the effectiveness of binocular 3D endoscopy during sinonasal and skull-base surgery. The technology facilitated depth perception and completeness of surgery without increase in complications. Additional experience is warranted to define its role in the endoscopic surgical paradigm.
Copyright © 2011 American Rhinologic Society-American Academy of Otolaryngic Allergy, LLC.

Entities:  

Mesh:

Year:  2011        PMID: 22287372     DOI: 10.1002/alr.20012

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

2.  Transnasal 3D endoscopic skull base surgery: questionnaire-based analysis of the learning curve in 52 procedures.

Authors:  G Felisati; C Pipolo; A Maccari; A Cardia; M Revay; G B Lasio
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-06       Impact factor: 2.503

3.  Endoscopic expanded endonasal approach: preliminary experience with the new 3D endoscope.

Authors:  G Felisati; R Lenzi; C Pipolo; A Maccari; F Messina; M Revay; A Lania; A Cardia; G Lasio
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-04       Impact factor: 2.124

4.  The effect of three-dimensional visualisation on performance in endoscopic sinus surgery: A clinical training study using surgical navigation for movement analysis in a randomised crossover design.

Authors:  Ellen Ten Dam; Herman M Helder; Bernard F A M van der Laan; Robert A Feijen; Astrid G W Korsten-Meijer
Journal:  Clin Otolaryngol       Date:  2020-01-27       Impact factor: 2.597

5.  Comparative effectiveness of 3-dimensional vs 2-dimensional and high-definition vs standard-definition neuroendoscopy: a preclinical randomized crossover study.

Authors:  Hani J Marcus; Archie Hughes-Hallett; Thomas P Cundy; Aimee Di Marco; Philip Pratt; Dipankar Nandi; Ara Darzi; Guang-Zhong Yang
Journal:  Neurosurgery       Date:  2014-04       Impact factor: 4.654

Review 6.  Endoscopic endonasal technique: treatment of paranasal and anterior skull base malignancies.

Authors:  Pornthep Kasemsiri; Daniel Monte Serrat Prevedello; Bradley Alan Otto; Matthew Old; Leo Ditzel Filho; Amin Bardai Kassam; Ricardo Luis Carrau
Journal:  Braz J Otorhinolaryngol       Date:  2013 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.